TickerFacts.

MaxCyte, Inc. (MXCT): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$34.41M
Year ended 2025-12-31
-$22.98M
Trailing 12 months to 2026-06-30
2019-12-31: -$8.80M2020-12-31: -$8.78M2021-12-31: -$10.68M2022-12-31: -$14.78M2023-12-31: -$21.69M2024-12-31: -$27.61M2025-12-31: -$34.41M-$34.41M
2019-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$34.41Mn/m2026-03-25, From 2025-01-01
2024-12-31-$27.61Mn/m2026-03-25, From 2024-01-01
2023-12-31-$21.69Mn/m2025-03-11, From 2023-01-01
2022-12-31-$14.78Mn/m2024-03-12, From 2022-01-01
2021-12-31-$10.68Mn/m2023-03-15, From 2021-01-01
2020-12-31-$8.78Mn/m2022-03-22, From 2020-01-01
2019-12-31-$8.80Mn/a2022-03-22, From 2019-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
MaxCyte, Inc. (MXCT)2025-12-31-$34.41Mn/m
OmniAb, Inc. (OABI)2025-12-31-$36.45Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$3.87Mn/m
NRC Health (NRC)2025-12-31$26.45M-23.6%
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$9.33Mn/m
Absci Corp (ABSI)2025-12-31-$92.92Mn/m
iSpecimen Inc. (ISPC)2025-12-31-$4.24Mn/m
OneMedNet Corp (ONMD)2025-12-31-$7.50Mn/m
Medpace Holdings, Inc. (MEDP)2025-12-31$713.22M+17.1%

Compare MXCT, OABI, FOXO, NRC side by side · Screen every company in Services-Commercial Physical & Biological Research ↗